Karmanos Cancer Center
Locations
Transplant Summary
Overview
Our institute provides care to patients receiving autologous, related and unrelated allogeneic, cord blood and mismatched stem cell transplants. Research efforts are aimed at preventing and treating graft-versus-host disease, targeting patient immune cells to kill cancer cells and chemotherapy dose escalation for the treatment of hematological cancers.This center has been performing allogeneic transplants since 1987 and has been an NMDP transplant center since August 1992.
Attending physicians
Adult - Lois Ayash, Abbinav Deol, Andrew Kin, Dipenkumar Modi, Joseph UbertiTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult onlyOther programs and services
Karmanos Cancer Center has discounted pricing with several local hotels in the area. The BMT Coordinator can provide additional information.Patient survival information for this center
This center's actual 1-year survival results are below the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 269 patients.The actual 1-year survival of these patients is 61.9%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 65.4% and 75.7%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
487
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total Marrow0PBSC17Cord blood0Total17Marrow2PBSC145Cord blood0Total147Marrow2PBSC162Cord blood0Total164MarrowBoth marrow & PBSC 323PBSC—Cord blood—Total323MarrowBoth marrow & PBSC 487PBSC—Cord blood0Total487All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44945-64465+4Total17Unrelated 0-18019-441845-646665+63Total147Autologous 0-18019-442945-6415565+139Total323Total 0-18019-445645-6422565+206Total487Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
No survivorship program information is available. Contact the center for information about post-transplant care.